SiteOne Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2010-01-01
- Employees
- 1
- Market Cap
- -
Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ST-2427
- First Posted Date
- 2020-07-17
- Last Posted Date
- 2023-08-03
- Lead Sponsor
- SiteOne Therapeutics, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT04475198
- Locations
- 🇺🇸
Altasciences, Overland Park, Kansas, United States
© Copyright 2025. All Rights Reserved by MedPath